Immunome IMNM
NASDAQ IMNM
$19.36 +0.65 (+3.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Immunome (IMNM) Total Debt (2020 - 2021)

Updated

Immunome's Total Debt was $500,000 in Q1 2021, unchanged from the prior quarter.

Analysis

Immunome (IMNM) Total Debt (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 44.65 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 80.90 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -11.96 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 26.23 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 62.67 Bn
10 Immunome 2.20 Bn 169.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 500,000.00
Dec 31, 2020 500,000.00
Sep 30, 2020 500,000.00
API Access

Immunome Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IMNM&period=max&api_key=YOUR_API_KEY